Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Penicillamine-induced skin lesions

I Sternlieb, M Fisher, I H Scheinberg

    The Journal of Rheumatology. Supplement
    |January 1, 1981
    PubMed
    Summary

    D-penicillamine treatment can cause diverse skin lesions through various mechanisms, including sensitivity, metabolic, and autoimmune effects. These side effects are influenced by the patient

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Summing up.

    Proceedings of the Royal Society of Medicine·2010
    Same author

    Homologous serum jaundice; a problem in the operation of blood banks.

    Journal of the American Medical Association·2010
    Same author

    The effects of cytochrome c on anoxic and cyanidepoisoned rats.

    The Journal of biological chemistry·2010
    Same author

    Morning panel discussion.

    Bulletin of the New York Academy of Medicine·2009
    Same author

    Orthotopic liver transplantation for Wilson's disease: a single-center experience.

    Transplantation·2001
    Same author

    Wilson's disease.

    Clinics in liver disease·2001

    Area of Science:

    • Dermatology
    • Pharmacology
    • Immunology

    Background:

    • D-penicillamine is a chelating agent used to treat various conditions.
    • Skin reactions are a known, albeit complex, side effect of D-penicillamine therapy.

    Purpose of the Study:

    • To categorize the diverse skin lesions associated with D-penicillamine therapy.
    • To elucidate the underlying mechanisms of these dermatological side effects.

    Main Methods:

    • Review of clinical presentations of skin lesions in patients treated with D-penicillamine.
    • Analysis of potential etiological factors including drug sensitivity, metabolic disturbances, and autoimmune responses.

    Main Results:

    • D-penicillamine-induced skin lesions manifest through acute sensitivity reactions.
    • Metabolic alterations and autoimmune phenomena are also implicated in lesion development.
    • The specific type and frequency of skin lesions vary based on the underlying disease, dosage, and treatment duration.

    Conclusions:

    • D-penicillamine therapy is associated with a wide spectrum of skin manifestations.
    • Understanding these mechanisms is crucial for managing patient safety and treatment efficacy.

    Related Experiment Videos